Clinical comparative study of zoledronic acid versus pamidronate disodium in the treatment of pain of skeletal metastases lung cancer

Chinese Journal of Cancer Prevention and Treatment

Volumn 15, Issue 9, 2008, Pages 707-708

  Shi, Xun ^a,b   Teng, Li Song ^a   Yu, Xin Min ^b   Ma, Sheng Lin ^b  

^a ZHEJIANG UNIVERSITY   (China)

^b Center of Chemotherapy   (China)

Author keywords

Bone pain; Lung neoplasms; Osseous metastasis; Zoledronic acid pamidronate disodium

Indexed keywords

PAMIDRONIC ACID; ZOLEDRONIC ACID;

ADULT; AGED; ARTICLE; BONE METASTASIS; BONE PAIN; CLINICAL ARTICLE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; LUNG CANCER; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; RANDOMIZED CONTROLLED TRIAL; STATISTICAL SIGNIFICANCE; UNSPECIFIED SIDE EFFECT; VISUAL ANALOG SCALE;

EID: 77953441212     PISSN: 16735269     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (5)

1. Chinese source.
2. Chinese source.
3. Ross J R, Saunders Y, Edmonds P M, et al. Systematic review of role of bisphosphonates on skeletal morbidity in metastatic cancer[J]. BMJ, 2003, 327: 469.
4. Rosen L S, Gordon D, Kaminski M, et al. Zoledronic acid versus pamidronate in the treatment of skeletal metastases in patients with breast cancer or osteolytic lesions of multiple myeloma: a phase III, double-blind, comparative trial[J]. Cancer, 2001, 7: 377-387.
5. Rosen L S, Gordon D, Tchekmedyian S, et al. Zoledronic acid versus placebo in the treatment of skeletal metastases in patients with lung cancer and other solid tumors: a phase III, double-blind, randomized trial[J]. J Clin Oncol, 2003, 21(16): 3150-3157.